Bell Investment Advisors, Inc Neurocrine Biosciences Inc Transaction History
Bell Investment Advisors, Inc
- $574 Million
- Q2 2025
A detailed history of Bell Investment Advisors, Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 47 shares of NBIX stock, worth $6,808. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 30
56.67%
Holding current value
$6,808
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NBIX
# of Institutions
718Shares Held
102MCall Options Held
228KPut Options Held
336K-
Black Rock Inc. New York, NY14.2MShares$2.06 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$1.41 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.56MShares$805 Million0.45% of portfolio
-
Jpmorgan Chase & CO New York, NY4.73MShares$685 Million0.04% of portfolio
-
State Street Corp Boston, MA4.35MShares$630 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...